Angiosarcoma Awareness is a patient-driven nonprofit dedicated to researching better therapies and a cure for angiosarcoma. Their hope is to fund research that will reveal the molecular underpinnings of the disease which might help tailor individual therapies.

The purpose of the Chondrosarcoma (CS) Foundation is to educate the public about Chondrosarcoma, support and advocate for patients and families that are suffering from this disease, and advocate to improve the treatment and care for these patients. 

The Chordoma Foundation is a patient-centered organization that strategically invests in mutually reinforcing programmatic areas that support the research to find better treatments, patient services to create better experiences, and healthcare improvements to drive better care. 

The Clear Cell Sarcoma Foundation (formerly Sara’s Cure) has one mission - to make Clear Cell Sarcoma survivable through education and scientific research while ensuring all patients and caregivers impacted have a voice and platform to enact change and strive towards the cure.

The mission of the Desmoid Tumor Research Foundation (DTRF) is to aggressively fund research to accelerate the development of improved therapies and ultimately find a cure for desmoid tumors. The DTRF collaborates with dedicated researchers and clinicians worldwide to improve the lives of patients through education, awareness and support.

Dragon Master Initiative’s mission is to find and accelerate cures for cancers, with a special focus on pediatric brain cancers, by fostering and rewarding a community of collaboration and innovation. They seek to expedite research, development, and treatments as well as to improve the quality of life for patients and their families.

The Epithelioid Hemangioendothelioma (EHE) Foundation’s mission is to seek treatments and a cure for Epithelioid Hemangioendothelioma (EHE) by increasing awareness, pursuing scientific research, advocating for and supporting EHE patients, and bridging information between researchers, providers and patients

The Fibrolamellar Cancer Foundation (FCF) is committed to finding a cure and supporting those impacted by fibrolamellar. FCF has committed over $8 million to fund research studies conducted by many of the most prestigious and innovative research and academic institutions in the country.

Global Patient Advocacy Coalition (GPAC) is committed to working collaboratively to endorse, support, and empower global patient advocates. GPAC strives to help every patient make educated and informed decisions about their medical procedures. GPAC teams work collaboratively with the FDA, medical providers, legislators, and other advocates to improve patient safety and the overall standard of care. 

The Head and Neck Cancer Alliance (HNCA) works with health professionals, caregivers, and patients to enhance the overall effort in prevention, treatment, and detection of cancers of the head and neck region.

The mission and sole commitment of the Jedi Rare Cancer Foundation is to accelerate scientific discovery that will change lives and enable better outcomes for rare cancer patients and their families.

The KCA seeks to be the leading source of education and resources for patients, caregivers, and anyone impacted by kidney cancer. We also promote the science of kidney cancer through two annual research symposiums and a robust grant program as well as participate in legislative advocacy efforts.

The Leiomyosarcoma Support and Direct Research Foundation (LMSDR) is dedicated to improving patient outcomes by supporting Leiomyosarcoma research, providing patient education and support, and fostering collaborative efforts.

The LUNGevity Foundation is dedicated to funding scientific research, advocating for the lung cancer community, and empowering patients to be active decision makers in their treatment process.

The Lonon Foundation supports children impacted by a parent's cancer diagnosis. Through our free resources we promote coping and resilience, helping children find comfort, heal, and grow from their shared experiences.

The Max Vincze Foundation funds innovative research to discover therapies for NUT carcinoma and other rare young adult cancers.

The mission of the Melanoma Research Alliance (MRA) is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.

The MET Crusaders is a community of lung cancer patients, care givers, advocates, researchers, and physicians dedicated to helping patients with the MET alteration live normal lives.

MIB Agents is a leading pediatric osteosarcoma nonprofit dedicated to making it better for the osteosarcoma community of patients, caregivers, doctors, and researchers through programs, education and research.  

Founded by patients for patients, the MPN Research Foundation is a catalyst for research funding in pursuit of new treatments – and eventually a cure – for myeloproliferative neoplasms (MPNs). 

The National LeioMyoSarcoma Foundation is dedicated to providing education, advocacy, support, and research for the LMS Community as they move forward in the quest for the cure.

The Neuroendocrine Tumor Research Foundation (NETRF) offers information and education to those with neuroendocrine tumors and  is the leading private funder of research into causes and treatments of neuroendocrine tumors (NETs) in the search for a cure. 

No Stomach for Cancer helps advance awareness and education about stomach cancer, including Hereditary Diffuse Gastric Cancer (HDGC). They also support research efforts for screening, early detection, treatment, and prevention of stomach cancer.

The NUT Carcinoma Support page provides support for patients, friends and families of those diagnosed with NUT Carcinoma.

Oligo Nation was founded to bring the oligodendroglioma community together and mobilize around funding medical research for new, more effective treatments. Their research strategy is to capitalize on the breakthrough approaches succeeding against other cancers, but which have not been tested against Oligo, including immunology and stem cell therapies.